New publication illustrates how the different members of the Vaccine Alliance work together and bring their unique skills and competencies to our public-private partnership.

The Investment Opportunity for the 2021-2025 period highlights the Alliance’s ambition to build on its success by providing the most comprehensive package of protection yet.

The 20 year history of an Alliance that today protects half the world’s children.

In November 2018, the Gavi Board approved allocation of USD 13.5 million as funding to support a three-year multi-faceted programme to improve yellow fever laboratory capacity in Africa during 2019-2021. This document is the public summary of the supply and procurement roadmap for yellow fever laboratory diagnostics for routine and outbreak yellow fever testing.